Programs, populations, and payments verified via SAMHSA.
- Level of care
- Inpatient · PHP · MAT · Telehealth
- Service settings
- Outpatient, Residential/24-hour residential, Outpatient day treatment or partial hospitalization, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment, Long-term residential, Short-term residential
- Therapy approaches
- Anger management, Cognitive behavioral therapy, Contingency management/motivational incentives, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Telemedicine/telehealth therapy, Trauma-related counseling
- Age groups
- Young Adults, Adults
- Special populations
- Adult women, Pregnant/postpartum women, Adult men, Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma
- Medications used
- Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Naltrexone (oral), Medication for mental disorders, Non-nicotine smoking/tobacco cessation
- Recovery supports
- Self-help groups, Housing services, Assistance with obtaining social services, Mentoring/peer support, Employment counseling or training
- Facility operation
- Local, county, or community government